Paper on Clinical Trial of MUCODYNE® for COPD Patients (PEACE Study) Chosen for THE LANCET Paper of the Year 2008
January 29, 2009
Tokyo-January 29, 2009, KYORIN Co., Ltd. announces that a research paper※1on a clinical trial (PEACE Study※2) of MUCODYNE®, sold by its wholly owned subsidiary KYORIN Pharmaceutical Co., Ltd. (Headquarters: Tokyo, President: Itaru Kojo), has been selected Paper of the Year by THE LANCET.
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.